Groundbreaking biocontrol solutions for a resilient agriculture

Introduction

Pertinent is developing products that combine the effectiveness of chemical pesticides with the safety of biocontrol products. Pertinent is applying to a blended funding program combining €2.5M of grants and €6M in direct investment to cover commercialization of its first products and its accelerated growth journey in the crop protection market.

Funding and Objectives

The funding coming from the EIC Accelerator Challenge 2023: Novel technologies for resilient agriculture will be critical to help Pertinent accomplish the following steps:

1. Conduct the final studies to lock the product formulation for the EU and the US.
2. Register the active substance and obtain market authorizations.
3. Build a commercialization organization in the EU and US.
4. Successfully launch the selected products in the targeted crops for the EU, USA, Brazil, and Mexico.
5. Build production capabilities in France to supply the growing demand (€10M in CapEx).
6. Build a R&D lab to formulate the new products, test them, and conduct analytical studies (€2M in CapEx).

Milestones

The main milestones of the project are:

• 2024: Launch of first crop protection biocontrol products in California (grape vines and berries).
• 2025: Temporary market authorization in the EU for sugar beets and grape vines; first launch in Mexico.
• 2028: Launch in Europe under full market authorization.

Partnerships and Support

Pertinent has already established a network of partners in Europe and the USA that will support its business efforts. These partners have provided letters of support in various areas:

• R&D (Universities, testing labs)
• Manufacturing (suppliers and contract manufacturers)
• Field testing and validation (Technical institutes)
• Commercialization (Distribution agreement already signed for Europe with De Sangosse)

Prominent investors have also expressed their strong interest in participating in the next round of funding along with the EIC.

Expected Outcomes

The expected outcomes of the program are the successful launch of one or two products in the EU, the USA, and Brazil and Mexico, generating €24.7M of sales in 2028.